TOP TIERMARKET NEWSWIRE
News & sentiment

LAKEFRONT BIOTHERAPE ADR (LKFT) — News & AI sentiment

LAKEFRONT BIOTHERAPE ADR (LKFT) news roundup. 2 stories in the past week, 9 over 30 days. Average 30-day sentiment is 61.1/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 56/100
30d stories
9
avg sentiment 61.1/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

LKFT news in the last 24 hours, 7 days, 30 days and 90 days

How much LKFT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowLKFT storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days256/100LKFT headlines →
Last 30 days961.1/100LKFT headlines →
Last 90 days1857.9/100LKFT headlines →

Latest stories on LKFT

5d ago
5d ago
Sep 1
Aug 25
Aug 24
Aug 24
Aug 24
Aug 24
TD Cowen upgrades Lakefront Biotherapeutics stock rating to buy
Investing.com Analyst Ratings61 · neutralanalyst
Aug 21
Aug 12
Aug 11
Lakefront Biotherapeutics reports Q2 results
Seeking Alpha50 · neutralearnings
Aug 10
Aug 10
Jul 28
Jul 20
Jul 13
Jul 10
Jun 30
Jun 9
Jun 9
Jun 7
Jun 5
Jun 4
Jun 4
May 20
Open LKFT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →